BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35953586)

  • 1. Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells.
    Rouhani FJ; Zou X; Danecek P; Badja C; Amarante TD; Koh G; Wu Q; Memari Y; Durbin R; Martincorena I; Bassett AR; Gaffney D; Nik-Zainal S
    Nat Genet; 2022 Sep; 54(9):1406-1416. PubMed ID: 35953586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cells derived from patients carrying mitochondrial mutations exhibit altered bioenergetics and aberrant differentiation potential.
    Meshrkey F; Scheulin KM; Littlejohn CM; Stabach J; Saikia B; Thorat V; Huang Y; LaFramboise T; Lesnefsky EJ; Rao RR; West FD; Iyer S
    Stem Cell Res Ther; 2023 Nov; 14(1):320. PubMed ID: 37936209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro erythrocyte production using human-induced pluripotent stem cells: determining the best hematopoietic stem cell sources.
    Cho YK; Kim HK; Kwon SS; Jeon SH; Cheong JW; Nam KT; Kim HS; Kim S; Kim HO
    Stem Cell Res Ther; 2023 Apr; 14(1):106. PubMed ID: 37101221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
    Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
    Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells.
    Ghosh Z; Wilson KD; Wu Y; Hu S; Quertermous T; Wu JC
    PLoS One; 2010 Feb; 5(2):e8975. PubMed ID: 20126639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human induced pluripotent stem cells from two azoospermic patients with Klinefelter syndrome show similar X chromosome inactivation behavior to female pluripotent stem cells.
    Panula S; Kurek M; Kumar P; Albalushi H; Padrell Sánchez S; Damdimopoulou P; Olofsson JI; Hovatta O; Lanner F; Stukenborg JB
    Hum Reprod; 2019 Nov; 34(11):2297-2310. PubMed ID: 31743397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlocking the Potential of Human-Induced Pluripotent Stem Cells: Cellular Responses and Secretome Profiles in Peptide Hydrogel 3D Culture.
    Cui M; Wu W; Li Q; Qi G; Liu X; Bai J; Chen M; Li P; Sun XS
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential Hematopoietic Differentiation in Induced Pluripotent Stem Cells Derived From Human Umbilical Cord Arterial Endothelial Cells.
    Pei H; Li H; Xu L; Zhang B; Zhang H; Jia Y; Liang L; Xie X; Fan Z; Yang Z; Wang X; Song F; He L; Yue W; Pei X
    Arterioscler Thromb Vasc Biol; 2023 May; 43(5):697-712. PubMed ID: 36951064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Normal or Mutated X-Linked
    El Ayachi I; Zou XY; Yan X; Lou Y; Huang GT
    J Dent Res; 2020 Feb; 99(2):196-203. PubMed ID: 31775564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells.
    Ruiz S; Diep D; Gore A; Panopoulos AD; Montserrat N; Plongthongkum N; Kumar S; Fung HL; Giorgetti A; Bilic J; Batchelder EM; Zaehres H; Kan NG; Schöler HR; Mercola M; Zhang K; Izpisua Belmonte JC
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16196-201. PubMed ID: 22991473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise Review: Assessing the Genome Integrity of Human Induced Pluripotent Stem Cells: What Quality Control Metrics?
    Assou S; Bouckenheimer J; De Vos J
    Stem Cells; 2018 Jun; 36(6):814-821. PubMed ID: 29441649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming enriches for somatic cell clones with small-scale mutations in cancer-associated genes.
    Kosanke M; Osetek K; Haase A; Wiehlmann L; Davenport C; Schwarzer A; Adams F; Kleppa MJ; Schambach A; Merkert S; Wunderlich S; Menke S; Dorda M; Martin U
    Mol Ther; 2021 Aug; 29(8):2535-2553. PubMed ID: 33831558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of protein-coding mutations in hiPSCs and their possible role during somatic cell reprogramming.
    Ruiz S; Gore A; Li Z; Panopoulos AD; Montserrat N; Fung HL; Giorgetti A; Bilic J; Batchelder EM; Zaehres H; Schöler HR; Zhang K; Izpisua Belmonte JC
    Nat Commun; 2013; 4():1382. PubMed ID: 23340422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes.
    Haile Y; Nakhaei-Nejad M; Boakye PA; Baker G; Smith PA; Murray AG; Giuliani F; Jahroudi N
    PLoS One; 2015; 10(3):e0119617. PubMed ID: 25789622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-Derived Human Induced Pluripotent Stem Cells From Gingival Fibroblasts Composited With Defined Nanohydroxyapatite/Chitosan/Gelatin Porous Scaffolds as Potential Bone Graft Substitutes.
    Ji J; Tong X; Huang X; Zhang J; Qin H; Hu Q
    Stem Cells Transl Med; 2016 Jan; 5(1):95-105. PubMed ID: 26586776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly efficient transfection of human induced pluripotent stem cells using magnetic nanoparticles.
    Yamoah MA; Moshref M; Sharma J; Chen WC; Ledford HA; Lee JH; Chavez KS; Wang W; López JE; Lieu DK; Sirish P; Zhang XD
    Int J Nanomedicine; 2018; 13():6073-6078. PubMed ID: 30323594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient generation of osteoclasts from human induced pluripotent stem cells and functional investigations of lethal CLCN7-related osteopetrosis.
    Rössler U; Hennig AF; Stelzer N; Bose S; Kopp J; Søe K; Cyganek L; Zifarelli G; Ali S; von der Hagen M; Strässler ET; Hahn G; Pusch M; Stauber T; Izsvák Z; Gossen M; Stachelscheid H; Kornak U
    J Bone Miner Res; 2021 Aug; 36(8):1621-1635. PubMed ID: 33905594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrospun polystyrene scaffolds as a synthetic substrate for xeno-free expansion and differentiation of human induced pluripotent stem cells.
    Leong MF; Lu HF; Lim TC; Du C; Ma NKL; Wan ACA
    Acta Biomater; 2016 Dec; 46():266-277. PubMed ID: 27667015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.